CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Exploratory Clinical Study of MT-2301 [Phase 2]
Summary
MT-2301 completed a Phase 2 exploratory study for Haemophilus influenzae type b infections; results were posted in September 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Haemophilus Influenza Type b | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19